MUDr. Ján Podhorec
Assistant professor, Comprehensive Cancer Care Department
Total number of publications: 37
2024
-
Transmembrane glycoprotein GPNMB is a candidate predictive biomarker and potentially a therapeutic target in metastatic renal cell carcinoma
Year: 2024, type: Conference abstract
2023
-
Next generation proteomics identifies a potential protein marker of poor response to tyrosine kinase inhibitors in metastatic renal cell carcinoma
Year: 2023, type: Conference abstract
-
Proteotype classification of localized and metastatic renal cell carcinoma for prognosis and therapy response
Year: 2023, type: Conference abstract
-
Proteotype classification of metastatic and localized renal cell carcinomas for prognosis and therapy response
Year: 2023, type: Conference abstract
-
Proteotypová klasifikace renálního karcinomu
Year: 2023, type:
-
Transmembrane glycoprotein GPNMB is a potential marker of poor response of metastatic renal cell carcinoma to tyrosine kinase receptor inhibitor treatment
Year: 2023, type: Conference abstract
2022
-
A large-scale assay library for targeted protein quantification in renal cell carcinoma tissues
Proteomics, year: 2022, volume: 22, edition: 7, DOI
-
DIA-MS identifies proteins associated with a poor response of metastatic renal cell carcinoma to tyrosine kinase inhibitor treatment
Year: 2022, type: Conference abstract
-
Identification of AGR2 Gene-Specific Expression Patterns Associated with Epithelial-Mesenchymal Transition
International Journal of Molecular Sciences, year: 2022, volume: 23, edition: 18, DOI
-
Metastatický HR+/HER2- karcinom prsu - léčba inhibitory CDK4/6, data z registru BRESCA
Year: 2022, type: Conference abstract